FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225655093> ?p ?o ?g. }

• W4225655093 abstract "Mendelian susceptibility to mycobacterial disease (MSMD) is a rare inherited disorder characterized by infections with weakly virulent mycobacteria in otherwise healthy individuals.1 MSMD is caused by genetic defects in genes coding for proteins in the IL-12/IFN-γ signaling pathway.2-4 IFN-γR1 deficiency is a common cause of MSMD.1, 5-7 The pathogenic variants in IFNGR1 can be either autosomal recessive (OMIM #209950) or dominant (OMIM #615978),8 resulting in complete or partial functional defects.7 Lack of surface expression leads to a complete loss of function. Expression of hypomorphic or amorphic IFN-γR1 can lead to either partial loss of function or have a dominant negative effect by impairing the wild-type allele. Complete loss of function in IFN-γR signaling results in severe mycobacterial infections in early childhood and poor survival, while variants with partial loss of function may result in a milder clinical phenotype that manifests later in childhood. A general approach in diagnosing patients with MSMD has been proposed in the literature using flow cytometry, lymphocyte immunophenotyping, and sequencing of genes known to be involved in mycobacterial host immunity.7, 9 However, since recent advances in genomic analysis technologies, a genotype-first approach for patients with a suspicion of an inborn error of immunity has currently become a more typical approach.10 While having the advantage of analyzing multiple genes simultaneously, some variants can be missed and the interpretation of the significance of novel variants or new combination of hypomorphic variants can be a diagnostic challenge. Here, we describe three patients with MSMD with novel or new combinations of hypomorphic variants in which functional assays were crucial to determine the extent of the interferon gamma receptor signaling defects. Patient 1 is a 6-year-old girl who was admitted to our pediatric ward with progressive cough, fever, and tachypnea. She is the only child of non-consanguineous parents (Figure 1A). Her medical history was remarkable with more than 20 hospital admissions for bronchial hyperreactivity, lower respiratory tract infections, and a coarctectomy at the age of 2. Imaging showed mediastinal and hilar lymphadenopathy, a large right upper lobe mass and lymph nodes compressing the trachea (Figure S1). An ultrasound showed three focal lesions in the spleen and hepatomegaly. Because of her severely compromised airway, steroids were given, improving intraluminal tracheal diameter. Histological examination on the lymph node ruled out malignant lymphoma. Sputum, stomach fluid, lymph node biopsy, and bone marrow culture revealed Mycobacterium avium. She was not vaccinated with Bacillus Calmette–Guérin (BCG). Plasma IFN-γ level on admission was elevated (311 pg/ml). She was treated with azithromycin, rifampicin, and ethambutol. Amikacine was added for the first 2 months. She recovered after a year of treatment. Patient 2 is a 7-year-old boy who was admitted with unexplained and recurrent low-grade fever, neck and leg pain, vasculitis-like skin lesions, and polydipsia for several months. He had a medical history with recurrent bronchial hyperreactivity, recurrent parotitis, parechovirus-associated radiculitis, and cluster headache. A brain MRI, CT scans of thorax and vertebrae, total body X-ray studies, and abdominal ultrasound showed a hypophysitis leading to panhypopituitarism, several bone lesions in skull, vertebrae and hip, hilar lymphadenopathy, and a single lesion in the spleen. Tuberculin skin test showed induration of 18mm. Cultures of a bone lesion and sputum grew Mycobacterium persicum. Patient 2 was also not vaccinated with BCG. Serum IFN-γ levels were undetectable. He started treatment with rifampicin, isoniazid, and ethambutol and hydrocortisone, levothyroxine, and desmopressin for his panhypopituitarism and has improved very well. Patient 3 is a 1-year-old girl with a swollen right upper arm and axillary lymphadenopathy. Her medical history showed bronchial hyperactivity and eczema. She was vaccinated for BCG during infancy and had a BCG scar that looked inflamed. A CT scan showed multiple active hilar and axillary lymph nodes, a splenic lesion and osteolytic lesions of her right humerus, two ribs, and a vertebral lesion in L2. Pathology of a bone biopsy from the right humerus showed lesions compatible with Langerhans cell histiocytosis (LCH). Treatment for multifocal LCH was started using prednisone and vinblastine. The bone lesions showed improvement, but new skin lesions appeared at the site of the BCG scar, head, and back. Repeated CT scans showed multiple bone lesions in scapulae, ribs, and progression of hilar and axillary lymphadenopathy. Skin biopsies of the lesions showed granulomatous infiltration and grew Mycobacterium bovis BCG strain. The previous diagnosis of LCH was re-evaluated, and a new diagnosis of BCG-osis was made. Treatment with rifampicin and isoniazid resulted in rapid improvement on skin and bone lesions and on lymphadenopathy. A diagnostic whole exome sequencing (WES)-based PID gene panel analysis was used as first-line diagnostic approach. In Patient 1, one heterozygous pathogenic variant in the IFNGR1 gene NM_000416.2 (IFNGR1):c.188T>G, p.(Val63Gly) was identified. However, no second variant was detected. Interestingly, only the IFNGR1 transcript with the p.(Val63Gly) variant was identified with RNA expression analysis (Figure 1B), and a SNP array showed decreased binding of one probe in exon 3 of IFNGR1. Long-range PCR using primers surrounding exon 3 showed a heterozygous insertion (Figure 1C). Sequence analysis revealed that this insertion concerned a complex insertion of 136 nucleotides of the right arm and the poly-A tail of an AluY transposable element combined with a 4-nucleotide duplication in exon 3: NM_000416.2(IFNGR1):c.210_211ins[136;A[?];207_210] (Figure 1D). Parental segregation analysis showed that the two variants were bi-allelic (Figure 1A). Patient 2 was compound heterozygous for a known pathogenic variant NM_000416.2 (IFNGR1):c.373 + 1G>T, p.(?) and variant NM_000416.2(IFNGR1):c.110T>C, p.(Ile37Thr), classified as probable pathogenic (Figure 1D). Parental segregation analysis showed that the two variants were bi-allelic (Figure 1A). In Patient 3, a novel variant in the STAT1 gene: NM_007315.3 (STAT1):c.1379A>T, p.(Asn460Ile) was identified (Figure 1C). This variant was not identified in the gnomADv2.1.1 control populations. Parental segregation analysis showed this was a de novo variant (Figure 1A). Functional analysis was performed to determine the effect on the IFN-γ/STAT1 signaling pathway. The surface expression of IFN-γR1 on monocytes was severely reduced in Patient 1 and Patient 2, while the expression was normal in Patient 3 (Figure 2A). In Patient 1 and 2, the expression of STAT1 was normal (Figure S2), while the phosphorylation of STAT1 was severely reduced in response to stimulation IFN-γ, but normal upon IFN-α stimulation (Figure 2B). Furthermore, the upregulation of the IFN-gamma-regulated genes SOCS1 and FCGR1B was absent after stimulation with IFN-γ (Figure 2C,D) and normal upon IFN-α stimulation (Figure 2C,D). In line with that, membrane expression of the IFN-gamma-regulated gene CD64 was not increased after IFN-γ stimulation in Patient 2 (Figure S3). These functional data suggest that Patient 1 and 2 have a defect in IFN-gamma signaling. For Patient 1, the life-threatening presentation of disease in combination with the results of the functional analyses led to refer her for an allogeneic hematopoietic stem cell transplantation, which was successful. The STAT1 gene variant p.(Asn460Ile) in Patient 3 is located in the DNA-binding domain of the STAT1 protein. Studies on the crystal structure of STAT1 showed that Asn460 is important for DNA binding since it is the only amino acid that directly interacts via hydrogen bonds to DNA, implying that this amino acid is crucial for STAT1 function.11, 12 In Patient 3, STAT1 protein expression was not affected (Figure S2), but the phosphorylation of STAT1 was slightly decreased (Figure 2B). Expression of SOCS1 and FCGR1B seemed normal after 0.5 h of stimulation with IFN-γ and IFN-α, but was reduced after 1 and 2 h of stimulation (Figure 2C). Together, these functional data and the fact that the variant is de novo strongly suggest that Patient 3 has an AD STAT1 deficiency. In conclusion, patients presenting with disseminated mycobacterial infections in early or late childhood with bi-allelic or nonconclusive genetic variants in genes involved in mycobacterial immunity need to be phenotyped by functional assays of the IFN-γ /STAT1 signaling pathway in monocytes. These assays are crucial in assessing the extent of IFN-γ pathway signaling defects and in clinical decision-making. The research for this manuscript was performed within the framework of the Erasmus Postgraduate School Molecular Medicine. The authors have no conflict of interest. Zijun Zhou: Data curation (equal); Formal analysis (equal); Investigation (equal); Visualization (equal); Writing – original draft (equal); Writing – review & editing (equal). Iris H.I.M. Hollink: Data curation (equal); Formal analysis (equal); Methodology (equal); Writing – review & editing (equal). Arjan Bouman: Data curation (equal); Formal analysis (equal); Writing – review & editing (equal). Mirthe S. Lourens: Data curation (equal); Formal analysis (equal); Writing – review & editing (equal). Rik A. Brooimans: Data curation (equal); Formal analysis (equal); Writing – review & editing (equal). Tjakko J. van Ham: Data curation (equal); Formal analysis (equal); Writing – review & editing (equal). Peter Fraaij: Conceptualization (equal); Investigation (equal); Writing – review & editing (equal). Annemarie van Rossum: Conceptualization (equal); Investigation (equal); Writing – review & editing (equal). Eline A.M. Zijtregtop: Data curation (equal); Investigation (equal); Writing – review & editing (equal). Willem A. Dik: Conceptualization (equal); Investigation (equal); Methodology (equal); Writing – review & editing (equal). Virgil van Dalm: Conceptualization (equal); Investigation (equal); Writing – review & editing (equal). Martin van Hagen: Conceptualization (equal); Investigation (equal); Writing – review & editing (equal). The peer review history for this article is available at https://publons.com/publon/10.1111/pai.13768. The peer review history for this article is available at https://publons.com/publon/10.1111/pai.13768. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article." @default.
• W4225655093 created "2022-05-05" @default.
• W4225655093 creator A5001894839 @default.
• W4225655093 creator A5015653388 @default.
• W4225655093 creator A5022752004 @default.
• W4225655093 creator A5026793311 @default.
• W4225655093 creator A5027727238 @default.
• W4225655093 creator A5032463262 @default.
• W4225655093 creator A5041124832 @default.
• W4225655093 creator A5055001889 @default.
• W4225655093 creator A5064245613 @default.
• W4225655093 creator A5065911146 @default.
• W4225655093 creator A5076842465 @default.
• W4225655093 creator A5085086839 @default.
• W4225655093 creator A5085206863 @default.
• W4225655093 creator A5087887942 @default.
• W4225655093 date "2022-04-01" @default.
• W4225655093 modified "2023-10-16" @default.
• W4225655093 title "Three patients with defects in interferon gamma receptor signaling: A challenging diagnosis" @default.
• W4225655093 cites W1502921690 @default.
• W4225655093 cites W1995225418 @default.
• W4225655093 cites W2052982889 @default.
• W4225655093 cites W2075482744 @default.
• W4225655093 cites W2156443053 @default.
• W4225655093 cites W2157376708 @default.
• W4225655093 cites W2614998011 @default.
• W4225655093 cites W2736640424 @default.
• W4225655093 cites W2954757609 @default.
• W4225655093 cites W3005125179 @default.
• W4225655093 cites W3011235227 @default.
• W4225655093 cites W3141879899 @default.
• W4225655093 doi "https://doi.org/10.1111/pai.13768" @default.
• W4225655093 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35470942" @default.
• W4225655093 hasPublicationYear "2022" @default.
• W4225655093 type Work @default.
• W4225655093 citedByCount "2" @default.
• W4225655093 countsByYear W42256550932022 @default.
• W4225655093 countsByYear W42256550932023 @default.
• W4225655093 crossrefType "journal-article" @default.
• W4225655093 hasAuthorship W4225655093A5001894839 @default.
• W4225655093 hasAuthorship W4225655093A5015653388 @default.
• W4225655093 hasAuthorship W4225655093A5022752004 @default.
• W4225655093 hasAuthorship W4225655093A5026793311 @default.
• W4225655093 hasAuthorship W4225655093A5027727238 @default.
• W4225655093 hasAuthorship W4225655093A5032463262 @default.
• W4225655093 hasAuthorship W4225655093A5041124832 @default.
• W4225655093 hasAuthorship W4225655093A5055001889 @default.
• W4225655093 hasAuthorship W4225655093A5064245613 @default.
• W4225655093 hasAuthorship W4225655093A5065911146 @default.
• W4225655093 hasAuthorship W4225655093A5076842465 @default.
• W4225655093 hasAuthorship W4225655093A5085086839 @default.
• W4225655093 hasAuthorship W4225655093A5085206863 @default.
• W4225655093 hasAuthorship W4225655093A5087887942 @default.
• W4225655093 hasBestOaLocation W42256550932 @default.
• W4225655093 hasConcept C126322002 @default.
• W4225655093 hasConcept C170493617 @default.
• W4225655093 hasConcept C203014093 @default.
• W4225655093 hasConcept C2776178377 @default.
• W4225655093 hasConcept C2778690821 @default.
• W4225655093 hasConcept C2780841837 @default.
• W4225655093 hasConcept C54355233 @default.
• W4225655093 hasConcept C62478195 @default.
• W4225655093 hasConcept C71924100 @default.
• W4225655093 hasConcept C86803240 @default.
• W4225655093 hasConceptScore W4225655093C126322002 @default.
• W4225655093 hasConceptScore W4225655093C170493617 @default.
• W4225655093 hasConceptScore W4225655093C203014093 @default.
• W4225655093 hasConceptScore W4225655093C2776178377 @default.
• W4225655093 hasConceptScore W4225655093C2778690821 @default.
• W4225655093 hasConceptScore W4225655093C2780841837 @default.
• W4225655093 hasConceptScore W4225655093C54355233 @default.
• W4225655093 hasConceptScore W4225655093C62478195 @default.
• W4225655093 hasConceptScore W4225655093C71924100 @default.
• W4225655093 hasConceptScore W4225655093C86803240 @default.
• W4225655093 hasIssue "4" @default.
• W4225655093 hasLocation W42256550931 @default.
• W4225655093 hasLocation W42256550932 @default.
• W4225655093 hasLocation W42256550933 @default.
• W4225655093 hasLocation W42256550934 @default.
• W4225655093 hasLocation W42256550935 @default.
• W4225655093 hasOpenAccess W4225655093 @default.
• W4225655093 hasPrimaryLocation W42256550931 @default.
• W4225655093 hasRelatedWork W2041591083 @default.
• W4225655093 hasRelatedWork W2044455389 @default.
• W4225655093 hasRelatedWork W2073241137 @default.
• W4225655093 hasRelatedWork W2130108353 @default.
• W4225655093 hasRelatedWork W2139453887 @default.
• W4225655093 hasRelatedWork W2168680345 @default.
• W4225655093 hasRelatedWork W2230586251 @default.
• W4225655093 hasRelatedWork W2313432370 @default.
• W4225655093 hasRelatedWork W2398766250 @default.
• W4225655093 hasRelatedWork W4231382084 @default.
• W4225655093 hasVolume "33" @default.
• W4225655093 isParatext "false" @default.
• W4225655093 isRetracted "false" @default.
• W4225655093 workType "article" @default.